– USA, ME – IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announced the election of Karen Peacock to its Board of Directors, effective October 6, 2025.
About Karen Peacock
Karen Peacock is the former Chief Executive Officer of Intercom, Inc., a customer service platform and leader in AI. Before Intercom, she spent approximately 14 years at Intuit Inc., a global SaaS software and financial technology company, where she held senior management positions of increasing responsibility, including as SVP of Intuit’s Small Business division.
Karen Peacock serves on the board of directors of Dropbox, a leading global collaboration platform, where she is the lead independent director.
Karen Peacock received her bachelor’s degree from Harvard University and her MBA from the Stanford Graduate School of Business.
About IDEXX Laboratories
IDEXX Laboratories, Inc., is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions—to advance medical care, improve efficiency, and build thriving practices. Our innovations also help ensure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&P 500 Index. Headquartered in Maine, IDEXX employs approximately 11,000 people and offers solutions and products to customers in more than 175 countries and territories.
For more: https://www.idexx.com/en/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.